181 related articles for article (PubMed ID: 28296794)
1. Solitary Large Keratoacanthomas of the Head and Neck: An Observational Study.
Rossi AM; Park B; Qi B; Lee EH; Busam KJ; Nehal KS
Dermatol Surg; 2017 Jun; 43(6):810-816. PubMed ID: 28296794
[TBL] [Abstract][Full Text] [Related]
2. Management of Keratoacanthoma: 157 Tumors Treated With Surgery or Intralesional Methotrexate.
Moss M; Weber E; Hoverson K; Montemarano AD
Dermatol Surg; 2019 Jul; 45(7):877-883. PubMed ID: 30608293
[TBL] [Abstract][Full Text] [Related]
3. [Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial].
Martorell-Calatayud A; Requena C; Nagore E; Sanmartín O; Serra-Guillén C; Botella-Estrada R; Sanz-Motilva V; Llombart B; Alcañiz-Moscardo A; Guillén-Barona C
Actas Dermosifiliogr; 2011 Oct; 102(8):605-15. PubMed ID: 21742301
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature.
Doerfler L; Hanke CW
J Drugs Dermatol; 2019 Jul; 18(7):693-696. PubMed ID: 31334929
[TBL] [Abstract][Full Text] [Related]
5. Multiple keratoacanthomas occurring in surgical margins and de novo treated with intralesional methotrexate.
Veerula VL; Ezra N; Aouthmany M; Graham TA; Wolverton SE; Somani AK
Cutis; 2016 Dec; 98(6):E12-E15. PubMed ID: 28099546
[TBL] [Abstract][Full Text] [Related]
6. Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma.
Nofal A; Alakad R; Wahid R; Hoseiny HAM
Arch Dermatol Res; 2024 Jun; 316(7):400. PubMed ID: 38878177
[TBL] [Abstract][Full Text] [Related]
7. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature.
Annest NM; VanBeek MJ; Arpey CJ; Whitaker DC
J Am Acad Dermatol; 2007 Jun; 56(6):989-93. PubMed ID: 17504715
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
Bricca GM; Brodland DG; Ren D; Zitelli JA
J Am Acad Dermatol; 2005 Jan; 52(1):92-100. PubMed ID: 15627086
[TBL] [Abstract][Full Text] [Related]
9. Two perplexing skin tumors: microcystic adnexal carcinoma and keratoacanthoma.
Batsakis JG; el-Naggar AK; Weber RS
Ann Otol Rhinol Laryngol; 1994 Oct; 103(10):829-32. PubMed ID: 7944178
[TBL] [Abstract][Full Text] [Related]
10. Intralesional methotrexate as effective treatment in solitary giant keratoacanthoma of the lower lip.
Spieth K; Gille J; Kaufmann R
Dermatology; 2000; 200(4):317-9. PubMed ID: 10894963
[TBL] [Abstract][Full Text] [Related]
11. Treatment of keratoacanthomas with intralesional methotrexate.
Melton JL; Nelson BR; Stough DB; Brown MD; Swanson NA; Johnson TM
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1017-23. PubMed ID: 1810980
[TBL] [Abstract][Full Text] [Related]
12. Is the first-line treatment of keratoacanthomas surgical excision or injection of intralesional chemotherapy?
Hoegler KM; Schleichert RA
J Am Acad Dermatol; 2020 Nov; 83(5):1542-1543. PubMed ID: 32622139
[No Abstract] [Full Text] [Related]
13. Treatment of keratoacanthoma: Is intralesional methotrexate an option?
Patel NP; Cervino AL
Can J Plast Surg; 2011; 19(2):e15-8. PubMed ID: 22654538
[TBL] [Abstract][Full Text] [Related]
14. Conventional surgery compared with slow Mohs micrographic surgery in the treatment of lentigo maligna: a retrospective study of 62 cases.
Hilari H; Llorca D; Traves V; Villanueva A; Serra-Guillén C; Requena C; Llombart B; Sanmartín O; Guillén C; Nagore E
Actas Dermosifiliogr; 2012 Sep; 103(7):614-23. PubMed ID: 22572575
[TBL] [Abstract][Full Text] [Related]
15. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective case series.
Aubut N; Alain J; Claveau J
J Cutan Med Surg; 2012; 16(3):212-7. PubMed ID: 22713449
[TBL] [Abstract][Full Text] [Related]
16. Treatment of giant keratoacanthoma of the skin of the lower lip with intralesional methotrexate: a case report.
de Visscher JG; van der Wal KG; Blanken R; Willemse F
J Oral Maxillofac Surg; 2002 Jan; 60(1):93-5. PubMed ID: 11757016
[No Abstract] [Full Text] [Related]
17. Sclerosing squamous cell carcinoma of the skin, an underemphasized locally aggressive variant: a 20-year experience.
Salmon PJ; Hussain W; Geisse JK; Grekin RC; Mortimer NJ
Dermatol Surg; 2011 May; 37(5):664-70. PubMed ID: 21269350
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Hill D; Richards S; Paver R
J Am Acad Dermatol; 2005 Aug; 53(2):253-60. PubMed ID: 16021120
[TBL] [Abstract][Full Text] [Related]
19. Refractory aggressive keratoacanthoma centrifugum marginatum of the scalp controlled with the epidermal growth factor receptor inhibitor erlotinib.
Bulj TK; Krunic AL; Cetner AS; Villano JL
Br J Dermatol; 2010 Sep; 163(3):633-7. PubMed ID: 20222923
[TBL] [Abstract][Full Text] [Related]
20. Keratoacanthoma as a postoperative complication of skin cancer excision.
Goldberg LH; Silapunt S; Beyrau KK; Peterson SR; Friedman PM; Alam M
J Am Acad Dermatol; 2004 May; 50(5):753-8. PubMed ID: 15097960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
